Literature DB >> 28616850

The "broken chair" in patients with differentiated thyroid cancer.

Amanda La Greca1, Fabián Pitoia2, R Michael Tuttle3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28616850     DOI： 10.1007/s12020-017-1345-y

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  4 in total

1.  Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

Authors:  Fabián Pitoia; Laura Ward; Nelson Wohllk; Celso Friguglietti; Eduardo Tomimori; Alicia Gauna; Rosalinda Camargo; Mario Vaisman; Rubén Harach; Fernando Munizaga; Sandro Corigliano; Eduardo Pretell; Hugo Niepomniszcze
Journal:  Arq Bras Endocrinol Metabol       Date:  2009-10

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 4.  Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of view.

Authors:  Livia Lamartina; David S Cooper
Journal:  Endocrine       Date:  2015-01-10       Impact factor: 3.633
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.